LANSING, Mich., Sept. 23, 2013 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB:KBLB) ("Company"), the leading developer of advanced spider silk based fibers, today announced that the Company's Monster Silk™ recombinant spider silk fibers are stronger than the comparable weight of traditional structural steel.
"We've long believed that Monster Silk™ tensile strength is stronger than steel, but it's a bonus to be able to quantify and confirm some of its properties for potential commercialization partners," said Company founder and CEO, Kim K. Thompson.
"Since the Company is producing fibers that have never been produced before, we've decided that we will expand our ability to ascertain these results. Therefore, we are investing in testing and measurement equipment that will help us to accelerate the testing of our fibers' unique qualities in a more efficient manner. We believe that this will advance our ability to communicate intelligently with our potential commercialization partners, improve the effectiveness in the laboratory, and greatly reduce the commercialization timeline for future products that we plan on bringing online."
About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.
Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company's future and expectations other than historical facts are "forward-looking statements." These statements are made on the basis of management's current views and assumptions. As a result, there can be no assurance that management's expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as "believes," "plans," "expects," "anticipates," "foresees," "estimated," "hopes," "if," "develops," "researching," "research," "pilot," "potential," "could" or other words or phrases of similar import. Forward looking statements include descriptions of the Company's business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.
This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.
CONTACT: Ben Hansel, Hansel Capital, LLC. (720) 288-8495 ir@KraigLabs.com
Source:Kraig Biocraft Laboratories, Inc